No difference in plasma or urinary F2-isoprostanes among patients with Huntington's disease or Alzheimer's disease and controls

✍ Scribed by T. J. Montine; L. Shinobu; K. S. Montine; L. J. Roberts II; N. W. Kowall; M. F. Beal; J. D. Morrow

• Publisher: John Wiley and Sons
• Year: 2000
• Tongue: English
• Weight: 110 KB
• Volume: 48
• Category: Article
• ISSN: 0364-5134
• DOI: 10.1002/1531-8249(200012)48:6<950::aid-ana23>3.0.co;2-f